Surgery Partners (SGRY) shares surged 5.3% to close at $16.41 in the latest trading session, amidst unusually high trading volume. This rise comes after a 7.3% decline over the past month. The company anticipates releasing its second-quarter financial results soon, with expected earnings of $0.02 per share, reflecting an 88.2% year-over-year decrease, and revenues projected at $835.38 million, a 1.1% increase from the previous year.
Additionally, Surgery Partners has placed signature pages into escrow for the sale of its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to partner Intermountain Health. This move marks a significant step in SGRY’s portfolio optimization strategy.
The stock currently holds a Zacks Rank of #1 (Strong Buy), indicating strong investor sentiment despite the expected decline in earnings. Keeping an eye on SGRY developments will be essential as market responses to upcoming earnings estimates could impact stock performance.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
